Two cases showed a complete and partial response in two 69-year old and 76-year-old Caucasian males with pre-treated anti-PD-1 refractory MCC after concurrent PD1/PDL1 inhibition and T-VEC treatment [69]. This evidence concerns the gene PDCD1 and Merkel cell skin cancer.